Autoantibodies to the high-affinity IgE receptor in chronic urticaria: How important are they?

Current Opinion in Allergy and Clinical Immunology

Volumn 5, Issue 5, 2005, Pages 403-407

  Sheikh, Javed ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Autoimmune; Basophil; Chronic urticaria; Fc RI; Mast cell

Indexed keywords

AUTOANTIBODY; HISTAMINE; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN E RECEPTOR;

BASOPHIL; BINDING AFFINITY; CHRONIC URTICARIA; HISTAMINE RELEASE; HUMAN; MAST CELL; PREVALENCE; PRIORITY JOURNAL; REVIEW;

EID: 25144466871     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/01.all.0000182540.45348.bc     Document Type: Review

References (32)

1. Kaplan AP. Urticaria angioedema. In: Adkinson NFY Jr, Busse WW, Bochner BS, et al., editors. Allergy: principles and practice. Philadelphia: Mosby; 2003. pp. 1537-1558.
2. Kaplan AP. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol 2004; 114:465-474; quiz 475.
3. Sabroe RA, Grattan CE, Francis DM, et al. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999; 140:446-452.
4. Grattan CE, Wallington TB, Warin RP, et al. A serological mediator in chronic idiopathic urticaria: a clinical, immunological and histological evaluation. Br J Dermatol 1986; 114:583-590.
5. Nguyen L, Sheikh J, Lin CK, et al. Serial basophil histamine release correlates with the clinical course in a patient with autoimmune urticaria. J Allergy Clin Immunol 2000; 104:S40-S41.
6. Grattan CE, Francis DM, Hide M, Greaves MW. Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria. Clin Exp Allergy 1991; 21:695-704.
7. Sabroe RA, Francis DM, Barr RM, et al. Anti-Fc(episilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria. J Allergy Clin Immunol 1998; 102 (4 Pt 1):651-658.
8. Zweiman B, Valenzano M, Atkins PC, et al. Characteristics of histamine-releasing activity in the sera of patients with chronic idiopathic urticaria. J Allergy Clin Immunol 1996; 98:89-98.
9. Hide M, Francis DM, Grattan CE, et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993; 328:1599-1604.
10. Ferrer M, Kinet JP, Kaplan AP. Comparative studies of functional and binding assays for IgG anti-Fc(epsilon)Rlalpha (alpha-subunit) in chronic urticaria. J Allergy Clin Immunol 1998; 101:672-676.
11. Marsland AM, Soundararajan S, Joseph K, Kaplan AP. Effects of calcineurin inhibitors on an in vitro assay for chronic urticaria. Clin Exp Allergy 2005; 35:554-559. This groundbreaking study was the first of its kind to show that specific immunomodulatory drugs can inhibit the in-vitro histamine release assay.
12. Grattan CE, O'Donnell BF, Francis DM, et al. Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria. Br J Dermatol 2000; 143:365-372.
13. Tong U, Balakrishnan G, Kochan JP, et al. Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol 1997; 99:461-465.
14. Ferrer M, Nakazawa K, Kaplan AP. Complement dependence of histamine release in chronic urticaria. J Allergy Clin Immunol 1999; 104: 169-172.
15. Kikuchi Y, Kaplan AP. A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol 2002; 109:114-118.
16. Caproni M, Volpi W, Giomi B, et al. Chronic idiopathic and chronic autoimmune urticaria: clinical and immunopathological features of 68 subjects. Acta Derm Venereol 2004; 84:288-290. This was one of a limited number of studies comparing clinical differences between the autoimmune and non-autoimmune forms of chronic urticaria in a fairly large patient population.
17. Toubi E, Kessel A, Avshovich N, et al. Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients. Allergy 2004; 59:869-873. This describes a well done study evaluating factors that predict duration of chronic urticaria.
18. Fiebiger E, Hammerschmid F, Stingl G, Maurer D. Anti-FcepsilonRlalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship. J Clin Invest 1998; 101:243-251.
19. Soundararajan S, Kikuchi Y, Joseph K, Kaplan AP. Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria. J Allergy Clin Immunol 2005; 115:815-821. This innovative study was aimed at determining which autoantibodies are functional versus non-functional. The data sheds some light on why binding assays often do not correlate with histamine release assays.
20. Horn MP, Gerster T, Ochensberger B, et al. Human anti-FcepsilonRlalpha autoantibodies isolated from healthy donors cross-react with tetanus toxoid. Eur J Immunol 1999; 29:1139-1148.
21. Kikuchi Y, Kaplan AP. Mechanisms of autoimmune activation of basophils in chronic urticaria. J Allergy Clin Immunol 2001; 107:1056-1062.
22. Fusari A, Colangelo C, Bonifazi F, Antonicelli L. The autologous serum skin test in the follow-up of patients with chronic urticaria. Allergy 2005; 60:256-258. This unique study examined the persistence of positive autologous skin test results in patients both with and without concomitant evidence of Hashimoto's thyroiditis.
23. Asero R, Lorini M, Chong SU, et al. Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells. Clin Exp Allergy 2004; 34:1111-1114.
24. Gyimesi E, Sipka S, Danko K, et al. Basophil CD63 expression assay on highly sensitized atopic donor leucocytes - a useful method in chronic autoimmune urticaria. Br J Dermatol 2004; 151:388-396.
25. Yasnowsky KM, Schoen DJ, Vedanthan PK, et al. Chronic urticaria sera increase basophil CD203c surface expression. J Allergy Clin Immunol 2005; 115:8178.
26. Fagiolo U, Kricek F, Ruf C, et al. Effects of complement inactivation and IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticaria. J Allergy Clin Immunol 2000; 106:567-572.
27. Saini S, Vasagar K, Huang F, et al. Signaling defects in basophils in chronic urticaria. J Allergy Clin Immunol 2003; 111:S178.
28. Grattan CE, Walpole D, Francis DM, et al. Flow cytometric analysis of basophil numbers in chronic urticaria: basopenia is related to serum histamine releasing activity. Clin Exp Allergy 1997; 27:1417-1424.
29. Luquin E, Kaplan AP, Ferrer M. Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli. Clin Exp Allergy 2005; 35:456-460. This groundbreaking study showed us that cellular defects may well be present in chronic urticaria, but also raised some unanswered questions, making it clear that there is much that we still have to learn before we will fully understand the spectrum of chronic urticaria.
30. Vasagar K, Vonakis, BM, Viksman, et al. Evidence of in vivo basophil activation in chronic idiopathic urticaria. J Allergy Clin Immunol 2004; 113:S257.
31. Saini SS G, Jr. SG, Vasagar, K, Vonakis, BM. Relationship between syk protein and degranulation in basophils from chronic urticaria donors. J Allergy Clin Immunol 2004; 113:889.
32. Vonakis B, Nocka K, Rao S, et al. Modulation of signaling proteins in cultured mast cells from chronic idiopathic urticaria patients. J Allergy Clin Immunol 2004; 113:888.